0.12%| Prev Close: | 11.67 |
|---|---|
| Open: | 11.84 |
| Bid: | 12.04 x 1200 |
| Ask: | 12.20 x 400 |
| 1y Target Est: | 12.56 |
| Beta: | 1.25 |
| Next Earnings Date: | N/A |
| Day's Range: | 11.75 - 12.21 |
|---|---|
| 52wk Range: | 9.37 - 14.91 |
| Volume: | 31,295,330 |
| Avg Vol (3m): | 5,731,010 |
| Market Cap: | 6.14B |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.07 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trialsat Motley Fool(Mon 4:10PM EDT)
- Royalty raises Elan bid, issues ultimatum to shareholdersat Reuters(Mon 3:27PM EDT)
- Royalty ups Elan bid and issues shareholder ultimatumat Reuters(Mon 1:43PM EDT)
- Royalty Pharma Raises Bid for a Resistant Elanat New York Times(Mon 1:24PM EDT)
- InPlay: Elan issues resposne to Royalty Pharma announcement: will assess increased offer of $12.50 per shareBriefing.com(Mon 1:01PM EDT)
- Elan’s Response to Royalty Pharma AnnouncementBusiness Wire(Mon 1:00PM EDT)
- Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All CashPR Newswire(Mon 11:44AM EDT)
- [video] Faber Report: Royalty Pharma to Raise Elan Bidat CNBC(Mon 10:32AM EDT)
- [video] Faber Report: Actavis to Buy Warner Chilcottat CNBC(Mon 9:15AM EDT)
- Early Movers: YHOO, CPB, BA, GE & Moreat CNBC(Mon 8:00AM EDT)
- Elan Announces Transactions: Decisively Transforming the CompanyBusiness Wire(Mon 2:00AM EDT)
- Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021Business Wire(Mon 2:00AM EDT)
- This Week in Biotechat Motley Fool(Sat, May 18)
- The Billion Dollar COPD Deal: Who Gains The Most?at Seeking Alpha(Fri, May 17)
- Here's What Super-Investor Seth Klarman Has Been Buyingat Motley Fool(Thu, May 16)
Press Releases
- Elan’s Response to Royalty Pharma AnnouncementBusiness Wire(Mon 1:00PM EDT)
- Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All CashPR Newswire(Mon 11:44AM EDT)
- Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021Business Wire(Mon 2:00AM EDT)
Reports
- Market Edge Equity Research ReportMarket Edge(May 20)
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(May 20)
- Elan Corp ADSS&P Capital IQ – STARS Reports(May 18)